SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-029994
Filing Date
2021-03-01
Accepted
2021-03-01 16:15:38
Documents
13
Period of Report
2021-03-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm215762d2_8k.htm   iXBRL 8-K 30305
2 EXHIBIT 4.1 tm215762d2_ex4-1.htm EX-4.1 994960
  Complete submission text file 0001104659-21-029994.txt   1408920

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pbh-20210301.xsd EX-101.SCH 3211
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbh-20210301_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbh-20210301_pre.xml EX-101.PRE 22728
6 EXTRACTED XBRL INSTANCE DOCUMENT tm215762d2_8k_htm.xml XML 3505
Mailing Address 660 WHITE PLAINS RD. TARRYTOWN NY 10591
Business Address 660 WHITE PLAINS RD. TARRYTOWN NY 10591 (914) 524-6800
Prestige Consumer Healthcare Inc. (Filer) CIK: 0001295947 (see all company filings)

IRS No.: 201297589 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-32433 | Film No.: 21697930
SIC: 2834 Pharmaceutical Preparations